This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Explore Which Dividend Aristocrats Etf Is Best For Retirement, focusing on income reliability, cost, and suitability for a retirement portfolio.
23,402 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Amazon's MGM-backed film Project Hail Mary roared out of the gate with an $80.5 million opening in the U.S. and Canad...
When a space company announces a bold acquisition, investors sit up. This article breaks down what york space buys al...
The United States and Europe are pursuing different routes to regulate AI, and the early market impact is clear—from ...
A clear, investor-friendly look at Iridex's Q1 2026 performance and what it could mean for the full year. Learn the n...
Indianapolis offers affordable entry and steady rental demand for buyers, yet pockets of foreclosures add risk. This ...
A tectonic shift is quietly unfolding in mobility and AI. The trillion robotaxi boom real could power a new era of ea...
When celebrities make their relationship public, it isn’t just headlines that change. Janel Parrish Sasha Farber prov...
Investors are weighing Nvidia's aggressive capital return plans against the durability of its margins and evolving to...
A Thursday rally put Oklo in the spotlight after a strategic supply agreement. This piece breaks down what happened, ...
NVIDIA delivered a blockbuster quarter while Cerebras reported explosive inference speed that still risks negative ma...
Ford extended a four-session losing streak after a soft Q2 U.S. sales report, prompting a closer look at rivals GM an...